Aquiline Capital Partners (Aquiline), a private investment firm with over $10bn in AUM, has made a majority investment in PharmaForce, a pharmacy solutions provider to hospitals and health clinics. Financial terms of the deal have not been disclosed.
The provider has delivered 340B administration software to over 280 clients since its inception in 2017 and recently launched a pharmacy benefits management offering.
In a press statement, PharmaForce said that, with Aquiline’s backing, it will “accelerate strategic M&A and continue to expand its product capabilities”.
Get the week’s top news delivered directly to your inbox – Sign up for our newsletter
Piper Sandler served as financial advisor to PharmaForce. Legal counsel was provided by Taft and Ropes & Gray to PharmaForce and Aquiline respectively.
Source: Private Equity Wire
Can’t stop reading? Read more
Apollo and Sony to reconsider $26bn Paramount deal
Paramount Global was heading for a rocky start to trading today CNBC reported overnight that Sony...
EQT’s Sinding Says Buyout Firms Hunt for New Ways to Exit
A growing number of private equity giants are considering new ways of exiting their portfolio...
Blackstone-led consortium bids Haldiram Snacks at $8.5 billion
A consortium including Blackstone Singapore state fund GIC and Abu Dhabi Investment Authority...